REMINISCENCES OF ERVIN G ERDÖS
Abstract
This article includes personal reminiscence of the great scientist Ervin G Erdös (19222019). Dr Erdös was born in Budapest, where he studied medicine. He finished his medical school in Munich, and obtained MD degree in 1952. There he joined, as a postdoctoral fellow, Professor Eugen Werle who had earlier discovered kallikrein, an enzyme that liberates kinins from kininogen. Dr Erdös continued his work on peptides and peptidases at the universities of Pittsburgh, Oklahoma City, Dallas and Chicago. In his eighties, he retired from the University of Illinois, Chicago. His numerous contributions to science belong to three important areas: 1) enzymes that generate, inactivate, or modulate the activity of kinins and other biologically active peptides, 2) angiotensin-converting enzyme and 3) kinin receptors. These discoveries contributed to our understanding of several bioactive peptide systems. Dr Erdös also found important interactions of the renin-angiotensin and kallikrein-kinin systems.
References
Erdös EG. Peptides and the enzymes that release or inactivate them: A short history of my life and work entwined. In: Semenza G, and Turner A J, eds. Selected topics in the history of biochemistry: personal recollections VIII. Comprehensive Biochemistry. Vol. 43. New York: Elsevier B.V.; 2004. p. 279–354.
Yang HYT, Erdös EG, Levin Y. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochim Biophys Acta 1970;214:374–6.
Igić R, Sorrells K, Nakajima T, Erdös EG. Identity of kininase II with an angiotensin I converting enzyme. In: Back N, Sicuteri F, eds. Vasopeptides. Plenum Press, New York; 1972. p. 149–153.
Erdös EG, Deddish PA, Marcic BM. Potentiation of bradykinin actions by ACE inhibitors. Trends Endocrinol Metab 1999;10:223–9.
Igić R. An exploration of bioactive peptides: my collaboration with Ervin G. Erdös. J Biol Chem 2018;293:7907-15.
Igić R, Robinson CJG, Erdös EG. Angiotensin I converting enzyme activity in the choroid plexus and in the retinal. In: Buckley JP, Ferrario CM, eds. Central actions of angiotensin and related hormones. New York: Pergamon Press; 1977. p. 23-27.
Igić R, Kojović V. Angiotensin I converting enzyme (kininase II) in ocular tissues. Exp Eye Res 1980;30:299-303.
Choudhary R, Singh M, Kapoor MS, Singh A, Bodakhe SH. Therapeutic targets of renin-angiotensin system in ocular disorders. J Curr Ophthalmol 2016;29,7e16. http://dx.doi.org/10.1016/j.joco.2016.09.009.
Van Haeringen NJ. The renin-angiotensin system in the human eye. Br J Ophthalmol 1996;80:99-100.
Igić R. Four decades of ocular renin-angiotensin and kallikrein-kinin systems (1977-2017). Exp Eye Research 2018;166:74-83.
Igić R. Effect of oxotremorine on the acetylcholine content of whole brain and various brain regions in the pigeon. Br J Pharmacol 1971;42:303-4.
Igić R, Stern P. The effect of oxotremorine on the “free” and “bound” brain acetylcholine concentrations and motor activity in beri-beri pigeons. Can J Physiol Pharmacol 1971;49:985-7.
Erdös EG. Hypotensive peptides: bradykinin, kallidin, and eledoisin. In: Garattini S, Shore PA, eds. Advances in Pharmacology. Vol. 4. New York: Academic Press; 1966.
Erdös EG, ed. Bradykinin, kallidin, and kallikrein. In: Handbook of Experimental Pharmacology. Vol. 25. Heidelberg: Springer-Verlag; 1970.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).